Recent news releases
-
Oct 9, 2026 Apotex to announce second quarter fiscal 2027 financial results and host conference call on Nov. 12, 2026
-
Oct 5, 2026 Apotex Health Corp. announces closing of $1,250 million inaugural senior unsecured notes offering
-
Sep 29, 2026 Apotex Health Corp. announces $1,250 million inaugural senior unsecured notes offering
-
Sep 18, 2026 Apotex Health Corp. announces closing of upsized bought deal secondary offering
-
Sep 15, 2026 Apotex Health Corp. announces upsize of bought deal secondary offering to $850 million
-
Sep 15, 2026 Apotex Health Corp. announces $750 million bought deal secondary offering
-
Aug 12, 2026 Apotex Announces First Quarter 2027 Results
-
Jul 17, 2026 Apotex Receives Investment Grade Issuer Rating from Morningstar DBRS and Announces Amended & Restated Credit Agreement
-
Jul 8, 2026 Apotex expands U.S. hospital portfolio with launch of generic Infuvite® Adult and Pediatric Injection
-
Jul 1, 2026 Apotex completes previously announced strategic transaction with Cumberland Pharmaceuticals